Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-01-27 @ 8:27 PM
Study NCT ID:
NCT01343160
Status:
COMPLETED
Last Update Posted:
2021-04-21
First Post:
2011-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures
Sponsor:
W.L.Gore & Associates
Organization:
Study Overview
Official Title:
Multicenter Study of Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to generate clinical data to support the use of GORE® VIABIL® Biliary Endoprosthesis in the endoscopic and percutaneous treatment of benign biliary strictures.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: